Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Tharimmune, Inc. Director's Dealing 2025

Nov 5, 2025

34824_dirs_2025-11-05_573a2136-2b06-410e-a206-48f884a5f5ee.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tharimmune, Inc. (THAR)
CIK: 0001861657
Period of Report: 2025-11-03

Reporting Person: Appajosyula Sireesh (Director, CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-11-03 Stock Option $3.075 A 20000 Acquired 2035-11-03 Common Stock (20000) Direct